🔥🔥🔥 JOIN OUR STARTUP AMBASSADOR PROGRAM 🔥🔥🔥
    📣 Spread the news & get a PRO membership 3 months for FREE with all features🚀📈💵500 vouchers left • 3 months free

    Egalet

    Egalet is a specialty pharmaceutical company that develops and markets medicines for patients with acute and chronic pain. The company utilizes its proprietary Guardian Technology to create treatments with chemical and physical properties designed to resist common methods of opioid abuse. Its manufacturing process is the first to combine injection molding with pharmaceutical production for orally delivered products.

    Visit websiteWayne, United States
    Healthtech
    Pharmaceuticals
    Biotechnology

    Funding summary

    Total raised
    €22.1M
    Funding rounds
    2

    Investors in Egalet

    Investors on record for Egalet. Click any investor to view their CAPLINK profile and funding criteria.

    Fundraising for a startup like Egalet?

    Explore CAPLINK's investor database of thousands of active VCs and angels.

    Browse investors

    We use cookies to enhance your experience. Read our Privacy Policy